CANCER'S CAUSE, CANCER'S CURE (30 page)

Using the same enzyme (PNPase) that Dr. Ochoa discovered in the 1950s when the Beljanskis worked with him at New York University, Dr. Beljanski was able to create a DNA strand that did exactly what DNA should do—replicate itself and the genetic code it contains.

This was the phenomena he was researching up until the raid on his laboratory, and it is in keeping with the caliber of scientist that he was. Many of the best natural scientists have been known to turn their attention to philosophical issues as they near their careers’ termination.

The physicist Erwin Schršdinger, Ph.D., for example, famous for the role his imaginary cat played in quantum mechanical theory, published his lectures in a volume called
What Is Life?
His collection has been interpreted as predicting the genetic function of DNA. Christian DeDuve gave an account of the major events throughout evolution in his book popular among scientists and consumers alike,
Blueprint for a Cell: The Nature and Origin of Life
.

Beljanski’s last publication reported the results of an experiment he had worked on for many years, but in it, and typical of all of his work, he avoided philosophizing and instead clearly addressed one of the most fundamental problems in the evolution of life. He stated that it took the presence of iron for the enzyme PNPase to synthesize DNA. His new finding, as with many others described in the book you are reading now, have been ignored by the scientific and medical mainstreams. I couldn’t agree more with the eminent Swiss biologist, Dr. Maurice Stroun, who said emphatically to me, “Mirko’s discoveries must be rediscovered!” Dr. Stroun’s stated notion is what I am attempting to do by getting this book published, read, and its information acted upon. Such constructive movements will not only inspire new generations of researchers but will potentially save multi-millions of lives. Of that I am certain.

A Daughter’s Homage

Dr. Mirko Beljanski and his work could have suffered the fate of obscurity if it weren’t for the firm tenacity with which his daughter and wife pursued his legacy.

Mirko Beljanski was martyred by the French government. He spent his life bucking what was fashionable, pioneering research that the establishment feared and thus dismissed.

As he recognized that his death was imminent, Beljanski painstakingly went over his life’s work with his daughter, Sylvie, who diligently transferred all the information to which he still had access to America, where they hoped medical freedom still existed. His goal was to put his life’s work into “easy-to-understand language so that more people would access it.”
Finally, he requested that he be taken off all treatments so he could return home to die.

Sylvie Beljanski’s outstanding commitment to carry on with her father’s legacy has led to a number of remarkable events and inspired others to further achievements, which are becoming themselves part of the exceptional story.

Starting with my trip to France to collect the testimonies from cancer and HIV survivors and write this book, I was moved by the dedication of all those men and women who traveled to the CIRIS picnic to share with complete strangers how they were able to overcome sickness and offer their own recovery as a beacon of hope to others. Other journalists and photographers have also felt compelled to report these remarkable stories, and I am told that a fifty-minute documentary movie has been filmed. Since Dr. Beljanski’s death, lawyers have felt energized to fight for justice and try to undo, one by one, the wrong done against Mirko and Monique Beljanski. As a result, these two who were totally unprepared for litigation because of their mindset exclusively on science, were in the end again and again vindicated by the courts. In 1994, when Beljanski was accused of practicing medicine without a license, in an unprecedented move, the General Attorney put aside his papers and pleaded himself for a non-guilty verdict. After years of
pro bono
work, a French tax attorney got a Court of Appeal to side with Monique Beljanski and the French IRS dropped their unjustified request of more than 1 million Euros (about 1.5 million dollars).

After his death, his daughter, a lawyer, with the help of her mother, brought a case against France to the European court of Human Rights. On May 23, 2002, the court issued a decree claiming that Mirko Beljanski had been “denied a fair trial and the opportunity to defend his legacy and the scientific value of his research.” Moreover, the high court found
unanimously
that Beljanski’s “right to be granted a fair trial in a reasonable time frame had been seriously violated.”
Beljanski’s surviving family won a small cash damage claim in the lawsuit against their country in the name of Mirko Beljanski, and they used the cash settlement to set up a foundation in their father’s name, the Beljanski Foundation.

I am happy to report that CIRIS along with the Beljanski Foundation’s work on both sides of the Atlantic are engendering global interest in Mirko Beljanski. Exciting research projects involving other institutions are currently in the works. But in the end, the goal for Sylvie today is the same as it was for Mirko forty years ago. Although she is not working in the laboratory, she is still continuing his mission to educate people about the danger that environmental toxins present to health and to encourage them to look for ways to take charge of their own health. Her message stresses the importance of detoxification, the elimination of heavy metals and toxins that make the bed for debilitating conditions and over time gradually destabilize the secondary structure of the DNA’s double helix. The Beljanski legacy has now spanned continents and generations. But Sylvie, who speaks constantly at conferences globally about her father’s research and environmental toxins, says emphatically to anyone who will listen, “There is still so much left to do!” I can hear echoes of her father in that last battle cry, and I cannot think of a better legacy for a daughter to leave her father.

A Final Tribute

One of the purposes of this book is to rescue Dr. Beljanski’s life’s work from obscurity and present it to a world-wide audience of needy victims of illness. Additionally it is my heart-felt intention that somehow Mirko Beljanski will finally be awarded the professional recognition that he assuredly deserves. This book is also a call for the French Government to publically redress the gross injustice that Dr. Beljanski suffered due to its vindictive bureaucrats’ destructive excesses. The government of France has served its people and the rest of our world poorly, and it deserves censorship.

Dr. Mirko Beljanski could have lived a life of obscurity, a poor farmer tending his geese and pigs. He certainly was in danger of being long forgotten after his death, his research and his botanicals buried away in a filing cabinet in some musty old government building in Paris. But I have found in my long years as a medical researcher that great and lasting discoveries may remain hidden for a while, but they will all eventually see the light of day. The human spirit is indomitable. We do not want to condemn ourselves to lives of needless suffering, and the truth, as they say, will win out in the end.

There
is
hope for those who suffer from all those deadly diseases whose cures remain elusive. The German philosopher, Arthur Schopenhauer, once said, “All truth passes through three stages. First, it is ridiculed. Second, it is violently opposed. Third, it is accepted as being self-evident.” Dr. Mirko Beljanski’s ideas were once ridiculed by his peers. They were certainly violently opposed by the French government and their close cohorts, Big Pharma. With more research to validate the forwardlooking microbiologist’s work, I know with certainty that in my lifetime, I will see Dr. Mirko Beljanski’s botanicals accepted as a self-evident cure for cancer.

Notes to Preface

1
The Merck Manual of Medical Information
, Second Home Edition, “Cancer of the Pancreas.” Mark H. Beers, M.D., Editor-in-Chief, Merck Research Laboratories, Whitehouse Station, NJ, Diagnosis Section, 2003, P. 774.

2
Morgan, G., R. Ward, and M. Barton. “The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies.”
Clinical Oncology
2004, 16 (80:549-560).

3
Dr. Julian Whitaker’s Health & Healing
¨ published by Healthy Directions, LLC., Vol. 21, No. 3, March 2011, P. 1.

Notes to Introduction

4
CIRIS is an acronym that stands for the
Centre d’Innovations, de Recherches et d’Informations Scientifiques
, (Center of Scientific Innovations, Research, and Information). Led by Mme. Pierrette Weidlich and whose activities are located mainly in Europe, CIRIS works with the Beljanski Foundation and sponsors research and clinical trials testing Beljanski¨ products.

In the context of the national and international laws that govern the Public Health Association, who acts as an international civic Non- Governmental Organization (O.N.G.), CIRIS has several aims which are listed on the website. Please see www.Beljanski.com. CIRIS also periodically publishes a limited circulation journal printed in French and sold by subscription under the masthead title of
Dialogue
. It does not have a broad audience, but its information is vital for the advancement of cancer healing. The
Dialogue
journal’s editorial offices are located at the
Centre d’Innovations, de Recherches et d’Informations Scientifiques
, BP 36-38370 Saint-Prim, France. Tel. 04 74 56 58 00.

5
The American College for Advancement in Medicine (ACAM) is a not-for-profit Organization dedicated to educating physicians and other health-care professionals on the safe and effective application of integrative medicine. ACAM's healthcare model focuses on prevention of illness and strives for total wellness. ACAM is the voice of integrative medicine; its goals are to improve physician skills, knowledge and diagnostic procedures as they relate to integrative medicine; to support integrative medicine research; and to provide education on current standards of care as well as additional approaches to patient care. ACAM enables members of the public to connect with physicians who take an integrative approach to patient care and empowers individuals with information about integrative medicine treatment options. Celebrating more than a quarter century of service, ACAM represents over 1,500 physicians in thirty countries. ACAM is the largest and oldest organization of its kind in the world dedicated exclusively to serving the needs of the integrative medicine industry.

* For a full listing of all ACAM conventions, please visit www.acamnet.org.

*Integrative medicine combines conventional care with alternative medicine to improve patient care. Rather than practice one type of medicine, integrative physicians will often combine therapies and treatment approaches to ensure the best results for their patients. ACAM physicians do not shun western medicine, in fact they practice western care every day. ACAM physicians are unique in that they incorporate
appropriate
and proven alternative treatment options.

I possess a recorded interview that confirms Le Perlier’s story. It is of the French licensed physician, P. K, M.D., of Versailles who was contacted by Mitterrand through one Mme. Pinjon. Mitterrand’s official doctors, Drs. Gubler, Tareau, and Debé were not happy to share their patient with a newcomer. Dr. K. confirmed the efficacy of Dr. Beljanski’s botanicals for the control of prostate cancer not only for Mitterrand but also for many of his other male patients. To gain his information on audiotape, I sat with Dr. P. K and his wife at dinner in a swank Paris restaurant. The politically active physician spoke cautiously, haltingly, and with thought-filled projected intervals between statements. Getting definitive information from him was like pulling teeth, but I did receive some viable tidbits which confirmed his successful application of Beljanski’s botanicals, including the administration of them to President François Mitterrand. This same physician provided me with a patient history of an eight-year-old boy for whom he reversed aplastic anemia (greatly reduced quantities of all blood cells lines) by use of Beljanski’s therapies. With help from Dr. Beljanski’s supplements, Dr. K. also caused the large-sized mediastinum (chest cavity) lymphoma tumor of a middle-age man to disappear in three weeks. This result occurred after radiotherapy had failed to give any positive response. It was a miracle, the Versailles physician said. Furthermore, Dr. P. K. told me more about his therapeutic achievements. They included the elimination of cancers of the breast and thymus by having his patients closely follow Dr. Beljanski’s therapeutic recommendations.

7
Causse, J.E.; Nawrocki, T.; Beljanski, M. “Human skin fibrosis RNase search for a biological inhibitor-regulator.”
Deutsche Zeitschrift fur Onkologie
23(5):137-139, 1994.

Notes to Chapter 1

8
Gros, F.; Beljanski, M.; Macheboeuf, M.; Grumbach, F. “Comparaison biochimique d’une souche bacterienne sensible ˆ la streptomycine avec une souche résistante de mﾐme espﾏce.”
C.R. Acad. Sci.
230:875-877, 1950.

Gros. F.; Beljanski, M.; Macheboeuf, M. “Mode d’action de la pénicilline chez
Staphylococcus aureus
inhibition d’un systﾏme enzymatique edtrait des bactéries.”
C.R. Acad. Sci.
231:184-186, 1950.

Gros. F.; Beljanski, M.; Macheboeuf, M. “Action de la pénicilline sur le métabolisme de la pénicilline sur le métabolisme de l’acide ribonucléique chez S
taphylococcus aureus.
”
Bull. Soc. Chim Biol.
33:1696-1717,1951.

Gros, F.; Beljanski, M.; Macheboeuf, M.; Grumbach, F.; Boyer, F. “Activie biologique des combinaisons streptomycine-acides gras.”
C.R. Acad. Sci.
232:764-766, 1951.